Dr. Dirk Weisensee
Angestellt, Biological Risk Manager, Xenios AG - a Fresenius Medical Care Company
Heilbronn, Deutschland
Werdegang
Berufserfahrung von Dirk Weisensee
Bis heute 6 Jahre und 6 Monate, seit 2018
Biological Risk Manager
Xenios AG - a Fresenius Medical Care Company
1997 - 2012
Senior Research Scientist
PHILIP MORRIS Research Laboratories GmbH
Study Director; COPD and Lung Cancer; In vitro models for human diseases (in vitro cell transformation, 3D models, Bronchial organotypical models at the Air-Liquid-Interface. Crossfunctional teams, Leader of "Organotypical Assays" development
Ausbildung von Dirk Weisensee
1982 - 1996
Biology
Goethe-University, Frankfurt Main
Post-doc; Cell Biology, Cardiology, Nephrology, Immunology, primary mammalian cells, co-culture, 3D, energy metabolism, perfusion, disease, uremia, cardiomyocytes, endothelium, Keratinocytes, smooth muscle, mesangium cells, Digital image analysis.
Sprachen
Deutsch
Muttersprache
Englisch
Gut